May 6, 2008 - VirtualScopics Inc. said today that its chief scientific officer, Edward Ashton, Ph.D., will deliver two speeches and co-author an abstract at the International Society for Magnetic Resonance Imaging in Medicine (ISMRM) conference in Toronto, Canada.

Ashton’s presentations on May 7 and 8 will focus on the company’s work in dynamic contrast-enhanced MRI, an advanced medical image analysis technique that measures blood flow and permeability and enables the early detection of a drug’s effectiveness in treating cancer and other diseases.

“Our proprietary analysis techniques surrounding the measuring of blood flow within a tumor continue to demonstrate great value to the industry,” Ashton said. “Because of the improved specificity and sensitivity of our tools we were able to determine that our method, compared to three other methods, was the only one that detected the treatment effect of our customer’s compound.”

For more information: www.virtualscopics.com


Additional Content

News | Radiology Imaging

Nov. 2, 2026 — Neurophet and RapidAI have partnered to integrate Neurophet’s advanced neurodegenerative brain imaging ...

Time November 04, 2026
arrow
News | Radiology Imaging

Oct. 19, 2026 — Paradromics Inc. has announced a collaboration with Siemens Healthineers to develop an advanced ...

Time October 26, 2026
arrow
News | FDA

Oct.7, 2026 – MRI2CT Inc. has received FDA 510(k) clearance for NextMR, its AI powered imaging platform, for generating ...

Time October 07, 2026
arrow
News | Information Technology

October 6, 2026 – Clearsense has introduced a cloud-based medical image archive designed to reduce the cost of ...

Time October 07, 2026
arrow
News | PET-MRI

Sept. 29, 2026 —Yale New Haven Hospital has installed a state-of-the-art positron emission tomography/magnetic resonance ...

Time October 05, 2026
arrow
Subscribe Now